HUM vs VRTX · P/E 39, rev $117.76B vs P/E 30, rev $12.00B
Humana Inc (HUM) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the HUM and VRTX stock pages for the full models.
Not investment advice.